COCP - Cocrystal Pharma, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 567.85M
Enterprise Value 357.09M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)11.97
Price/Book (mrq)0.93
Enterprise Value/Revenue 310.07
Enterprise Value/EBITDA 6-16.67

Trading Information

Stock Price History

Beta (3Y Monthly) -0.52
52-Week Change 3-31.29%
S&P500 52-Week Change 32.63%
52 Week High 35.2800
52 Week Low 31.5100
50-Day Moving Average 32.1894
200-Day Moving Average 32.4074

Share Statistics

Avg Vol (3 month) 35.26k
Avg Vol (10 day) 35.2k
Shares Outstanding 531.62M
Float 13.33M
% Held by Insiders 164.15%
% Held by Institutions 16.87%
Shares Short (Aug 15, 2019) 470.55k
Short Ratio (Aug 15, 2019) 416.99
Short % of Float (Aug 15, 2019) 40.51%
Short % of Shares Outstanding (Aug 15, 2019) 40.22%
Shares Short (prior month Jul 15, 2019) 489.89k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 230/1
Last Split Date 3Jan 24, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-61.55%

Management Effectiveness

Return on Assets (ttm)-2.17%
Return on Equity (ttm)-48.30%

Income Statement

Revenue (ttm)5.67M
Revenue Per Share (ttm)0.19
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-4.67M
EBITDA -3.42M
Net Income Avi to Common (ttm)-44.7M
Diluted EPS (ttm)-1.4670
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.47M
Total Cash Per Share (mrq)0.24
Total Debt (mrq)1M
Total Debt/Equity (mrq)1.39
Current Ratio (mrq)4.60
Book Value Per Share (mrq)2.29

Cash Flow Statement

Operating Cash Flow (ttm)-3.13M
Levered Free Cash Flow (ttm)-1.98M